ACET CIK: 1720580

Adicet Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
282
FY22:
261
FY23:
162
FY24:
180
FY25:
161
(positive)
Change from FY21 to FY25
millions USD
FY21:
56.5
FY22:
69.7
FY23:
45.0
FY24:
40.1
FY25:
31.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
339
FY22:
331
FY23:
207
FY24:
220
FY25:
192

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
16.3
FY22:
19.7
FY23:
19.3
FY24:
19.4
FY25:
21.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
19.5
FY22:
18.6
FY23:
17.8
FY24:
14.2
FY25:
11.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
303
FY22:
292
FY23:
170
FY24:
187
FY25:
159
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
339
FY22:
331
FY23:
207
FY24:
220
FY25:
192

All amounts in millions USD Data source:SEC EDGAR